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Abstract 
BACKGROUND: The development of encapsulation technologies has played an important role in 
improving cryopreservation outcomes for many cell and tissue types over the past 20 years. Alginate 
encapsulation cryopreservation (AECryo) has been incorporated into a range of applications in 
biotechnology, species conservation and clinical therapies, using cells from many different phyla, 
including higher plants, animal and human cells. This review describes the background to the origins 
of AECryo, the development of AECryo in higher plant tissues, broadening to current applications in 
algal conservation, the roles for AECryo in preserving phytodiversity, fungal species and in animal 
and human cells. OBJECTIVE: The main aims are to provide information resources on AECryo in 
different areas of biology and to stimulate new ideas for wider applications and future improvement. 
The translation of this useful biopreservation strategy into new opportunities for cell cryopreservation 
and storage at non-freezing temperatures are also discussed.   
Keywords: alginate, encapsulation, cryopreservation, plant tissues, algae, fungal species, mammalian 





Over the past two decades, applications of 
cryopreservation have proceeded hand in hand 
with developments of other technologies, which 
have been designed to address problems in 
biotechnology, cell therapy and species 
conservation. Cell encapsulation in alginate is 
one such technology, which can facilitate several 
critical steps within cryopreservation, such as 
controlled handling of sensitive cells or tissue, 
exposure to cryoprotectant agents, and enhanced 
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stability of the cryopreserved products (58, 92, 
127, 182). This review is aimed at providing 
current information on alginate encapsulated 
cryopreservation including the nature of the 
alginate biopolymer and challenges with its use 
in regulated cryopreservation practices, a history 
of alginate encapsulation cryopreservation 
(AECryo) and our understanding of the chemical 
and physical advantages of applying alginate 
technologies, and the results achieved so far 
across a range of different species. It is 
presented under the following headings: 
 
1. ALGINATE HYDROGEL AS A SAFE, 
CONTROLLED POLYMER FOR 
CRYOPRESERVATION. 
 
2. ALGINATE ENCAPSULATION IN PLANT 
CRYOPRESERVATION – HISTORICAL 
DEVELOPMENT OF AECryo CONCEPTS 
 
3. ALGINATE ENCAPSULATION FOR THE 
CRYOPRESERVATION OF ALGAE 
 
4. ALGINATE-BASED CRYOBIOLOGY FOR 
PHYTODIVERSITY CRYOPRESERVATION 
 
5. ALGINATE ENCAPSULATION FOR 
FUNGAL CRYO-STORAGE   
 
6.  ALGINATE ENCAPSULATION 
CRYOPRESERVATION APPLIED TO 
ANIMAL AND HUMAN CELLS AND STEM 
CELLS 
 
7. ALGINATE ENCAPSULATION FOR 
STORAGE OF CELLS AT NON-FREEZNG 
AND POSITIVE TEMPERATURES 
 
1. ALGINATE HYDROGEL AS A SAFE, 
CONTROLLED POLYMER FOR 
CRYOPRESERVATION. 
Alginates comprise a range of biopolymers, 
which can be extracted at commercial scales 
from brown algal species including Lessonia 
nigrescens and L. trabeculata and have been 
widely used in the food and pharmaceutical 
industries for many years (123, 162, 183) as 
bulking or stabilising agents due to their low 
toxicity. They are polysaccharide copolymers 
consisting of linear 1,4 linked residues of β-D-
mannuronic acid (M) and α-D-guluronic acid 
(G) arranged in blocks of consecutive M or G 
residues or mixed M and G residues (123, 162). 
Particular compositions are dictated by the 
species of origin and the environmental growth 
conditions, given that the algae are widely 
distributed around different continental 
coastlines (13, 163); for example, G composition 
can vary between 30 – 70%. These differences 
may be of relevance when selecting alginates for 
encapsulation cryopreservation since differences 
in M to G ratios can affect physical 
characteristics such as viscosity of the 
solubilised alginate or stiffness of the 
polymerised form (154, 183).  
Sodium alginate is provided as a 
commercial powder, which can be solubilised in 
aqueous solutions by extensive mixing. The 
polymerisation to a gel format suitable for 
encapsulation can be driven by addition of 
multivalent cations (such as Ca2+, Ba2+, Fe3+) 
which interact with carboxyl groups of the 
carbohydrate residues (123, 182), and due to 
toxicity issues surrounding metal ion exposure, 
Ca2+ has been most commonly used for 
encapsulation / cryopreservation. The M:G 
ratios of a particular alginate fraction, the 
viscosity of the solubilised form (which is 
related to concentration) and the cation 
employed in polymerisation were found to be 
the most important factors in determining the 
stability of the capsules produced after 
polymerisation (33, 154). In general, alginate 
has been found to be a non-toxic, biocompatible 
polymer with a wide range of cell based 
applications (75) and thus is a very useful 
candidate for encapsulation cryopreservation. 
The polymerisation process can be reversed by 
exposure to chelating agents such as EDTA (53), 
although this is not an often reported step in 
most encapsulation / cryopreservation strategies. 
Alginate encapsulated cells may also be subject 
to capsule instabilities when exposed for long 
durations to physiological monovalent cations 
which exchange with the divalent cations [for 
example after transplantation of cryopreserved 
encapsulated cells (19)] although this is not 
specifically related to the cryopreservation 
process.     
An important point when applying alginate 
encapsulation / cryopreservation is the potential 
contaminants in the crude commercial polymer, 
which can comprise inorganic and organic 
materials such as bacteria, fungi, animal waste 
and others encountered within the marine 
environment (155, 183). For example, spores of 
gram positive bacteria have been found in 
commercial alginate fractions (182).  Extraction 
processes to yield commercial polymer employ 
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chelation steps and washes in various organic 
solutions are standardised by adherence to 
American Society for Testing and Materials 
(ASTM) protocols (41), but these may not 
guarantee complete removal of biological 
contaminants.           
 
2. ALGINATE ENCAPSULATION IN 
PLANT CRYOPRESERVATION – 
HISTORICAL DEVELOPMENT OF 
AECryo CONCEPTS 
Immobilization and encapsulation 
technologies have been used over several 
decades in plant agriculture, biotechnology, 
forestry, horticulture and environmental 
sciences, thus reflecting their diverse 
applications across multidisciplinary sectors (85, 
118, 146). Plant technologies have in fact driven 
the conceptualisation and practical development 
of AECryo several years before their 
applications in animal or human cell cryo-
storage.  
 
Alginate encapsulation in plant biotechnology: 
cellular and developmental aspects 
The use of alginate bead encapsulation as a 
cryoprotective strategy is based on artificial seed 
technology and was first explored by Fabre and 
Dereuddre for potato shoot meristem 
cryostorage (47). The concept of making 
artificial seeds by encapsulating plant somatic 
embryos in calcium alginate was pioneered in 
the 1970s for clonally propagated species and 
elite genotypes (118). Dereuddre et al. (39) 
adapted the approach to cryopreserve alginate 
encapsulated somatic embryos of Daucus carota 
achieving > 90% survival after ultra-rapid 
cooling in liquid nitrogen (LN). Encapsulation 
has the advantage of allowing the direct transfer 
of clonal propagules to the glasshouse or field 
and it provides a convenient carrier for growth 
regulators, nutrients and antimicrobials. 
Incorporation of bioactive agents directly into 
the gel matrix supports the growth and 
development of somatic embryos, meristems, 
nodal segments and shoot cuttings and 
encapsulated propagules can be dried and stored 
until required for use. Synthetic seed technology 
has potential utility in horticulture (20) and the 
sustainable forest products sector (31) although 
commercial scale-up of ‘Synseeds’ is elusive in 
the conifer forestry (17).  
 The exploitation of alginate encapsulation 
in plant cryopreservation is also preceded by its 
 
Figure 1. Schematic generic representation of the typical process for alginate encapsulation, 
biospecimen processing and cryo-banking. After preparation, the biospecimen is soaked in 
sodium (Na) alginate solution and sprayed (or transferred) to polymerization solution 
containing multivalent cations (Ca2+, Ba2+, Fe3+). Following polymerization and washing steps, 
encapsulated biospecimens are ready for further processing and analysis. Cryopreservation 
of encapsulated samples may be conducted either directly by saturation with the 
cryoprotective solution and programmed freezing or rapid cooling, and progressed through an 




use in the natural products industries in which 
polymer matrices are used for the transformation 
and production of secondary metabolites from 
plant enzymes, cells, tissues and organs (21). 
Immobilization of plant cells in gels has 
advantages for large-scale culture in bioreactors 
as the process supports continuous operations 
and separates biomass from the medium. The 
productive life of immobilized cultures can be 
extended and encapsulation stimulates secondary 
metabolite production in some cell lines (137). 
Whilst alginate immobilization has proven its 
utility in plant biotechnology and 
biopreservation, little is known about how 
encapsulation influences plant cell metabolism, 
growth and development. Some clues can be 
found in the early plant protoplast literature, 
which reports that ageing in isolated protoplasts 
can be reduced by encapsulation. Schnabl et al.  
found that the immobilization of Vicia faba 
protoplasts in calcium alginate delayed the 
production of cell ageing biomarkers (133). 
Immobilization in the alginate matrix inhibited 
indicators (biomarkers) of free radical mediated 
lipid peroxidation, delayed pigment degradation 
and reduced protease activity. It was presumed 
that Ca2+ and alginate retarded degradation 
reactions, protected cell membranes and 
increased protoplast stability. Schnabl et al.  
inferred that when cells die in the gel matrix the 
proteolytic enzymes released diffuse slowly and 
are inhibited from degrading neighbouring 
viable cells and proposed alginate encapsulation 
as a protoplast storage method (133). 
Schlangstedt et al. (132) found that 
encapsulation stimulated the development of 
Beta vulgaris protoplasts in the presence of a 
nurse culture and suggested that alginate gels 
provide a ‘gentle environment’ that protects cells 
against mechanical damage.  
 
A novel approach to plant cryopreservation: 
encapsulation/dehydration 
Cryopreservation using alginate bead 
encapsulation was initially developed for potato 
by Fabre and Dereuddre (47), the motivation 
being that shoot meristems derived from in vitro 
cultures proved persistently difficult to 
cryopreserve  (18, 62). The novel idea of 
adapting artificial seed technology for 
cryostorage was tested as an alternative to using 
cryoprotectants combined with controlled rate 
cooling. In brief, the process involves: i) 
encapsulating shoot meristems in a calcium-
alginate matrix; (ii) osmotic dehydration of the 
bead/meristems in sucrose solutions; (iii) 
evaporative desiccation in a sterile air flow, or 
over silica gel or drying beads; (iv) direct 
plunging into LN; (v) rewarming at ambient 
temperature, usually in a laminar airflow 
cabinet; (vi) rehydration of the beads in liquid 
medium to remove sucrose; and (vii) transfer to 
recovery medium. Each step of the protocol is 
optimized for specific species and genotypes. 
Agents that support recovery and regrowth can 
be added to the alginate as demonstrated by the 
increased post-cryopreservation regeneration of 
yam shoot meristems in alginate beads loaded 
with melatonin (165). Encapsulation/dehydration 
has the advantage of being a ‘low tech’ 
cryopreservation protocol as it is amenable to 
laboratories that do not have access to controlled 
rate cooling equipment. However, good logistics 
and forward planning are required as the 
protocol involves multiple steps undertaken over 
1-2 days and the method can be labour intensive 
when processing large numbers of samples. To 
assure the reproducibility of the air desiccation 
step silica gel evaporation is advised for 
laboratories operating in unregulated ambient 
environments (143). Several modifications have 
been made to the original 
encapsulation/dehydration protocol to improve 
the tolerance of different plant species to 
dehydration and desiccation (105, 167, 171).  
Encapsulation/dehydration has been 
applied to over 70 plant species (51) and is 
particularly suitable for the cryopreservation of 
organized tissues such as shoot tips, somatic 
embryos and microspore embryos (38, 44, 59, 
119, 166). Encapsulation-based methods provide 
an alternative method for the cryopreservation of 
germplasm from plant species and genotypes 
that produce storage recalcitrant seeds and/or 
that do not respond to controlled rate cooling 
and for which chemical cryoprotectants may be 
toxic (9, 103). For certain sectors (e.g., 
horticulture, clonal forestry and agroforestry) 
alginate encapsulation has the advantage of 
combining artificial seed technology (59, 118) 
with in vitro conservation (31). 
Encapsulation/dehydration has been used for the 
cryopreservation of a broad range of plant taxa 
(51) including cryptogams (87) and the method 
has also been adapted for the ex situ 
conservation of rare species (50, 88). 
Encapsulation/dehydration protocols have been 
validated for the cryopreservation of clonal crop 
germplasm maintained in international 
genebanks (120, 122).  
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Although alginate-based cryopreservation 
was initially pioneered for tropical plants that 
are recalcitrant to other cryopreservation 
methods (45), desiccation-sensitive germplasm 
can still succumb to stress. Understanding the 
physiological basis of plant cryopreservation 
success and failure will be important for the 
improvement of cryostorage outcomes in the 
future (9, 56). This is also the case for temperate 
plants that have complex seasonal life cycles 
impacted by environmental cues (9, 49).  
Figure 2 demonstrates recovery responses 
for the initial survival of apical meristems (A) 
and lateral shoot regrowth (B) of Picea 
sitchensis (Sitka spruce) following alginate 
encapsulation/dehydration, evaporative 
desiccation and exposure to LN. After 
cryostorage some regrowth was observed (B) 
although necrosis occurred (C, D) following the 
initial recovery of the lateral meristem, which 
was not sustained in the longer-term. This study 
(49) addressed the importance of understanding 
the complex relationship between stress-induced 
dormancy and cryoinjury in the sustained 
recovery of encapsulated germplasm derived 
from a recalcitrant, temperate tree species which 
has a complex life cycle. The decline in viability 
over extended recovery times observed in Sitka 
spruce shoots shares commonality with the 
hypothesis of delayed onset, cryopreservation 
induced cell death which is attributed to 
apoptosis in the field of biomedical preservation 
(7).  
 
Enhancing the utility of alginate-based plant 
cryopreservation using encapsulation-
vitrification  
Matsumoto and Sakai (94) and Sakai et al. 
(127) modified the original 
encapsulation/dehydration method developed by 
Fabre and Dereuddre (47) and Dereuddre et al. 










Figure 2. Picea sitchensis (Sitka spruce) meristem apices recovering after cryogenic 
treatments. (A) green apical tissue (E+S+D = Encapsulation + Sucrose + Desiccation); (B) 
lateral meristem emerging from bead (E+S); (C) lateral meristematic dome, green primordia 
with black bud scales (E+S+D+LN); (D) initial lateral meristem regrowth followed by necrosis 
(E+S+D+LN). Meristem apices were assessed after 28 (A-C) and 48 days (D). Treatments: 
alginate encapsulation (E); 0.75 M sucrose for 18 h (E+S); 4 h air desiccation (E+S+D); LN 




step with osmoprotection in a solution of 
glycerol and sucrose which enhances resilience 
to osmotic dehydration and evaporative 
desiccation treatments. This approach was later 
developed as the ‘encapsulation-vitrification’ 
protocol by Sakai and colleagues (128) who 
applied it to shoot meristems from species 
sensitive to dehydration and desiccation. 
Encapsulation-vitrification combines alginate 
encapsulation with the application of 
cryoprotective additives [dimethylsulphoxide 
(DMSO), glycerol, sucrose, and ethylene glycol] 
that comprise Plant Vitrification Solution 
Number 2 (PVS2). The basic procedure 
involves: (i) pregrowth of donor shoots with 
sucrose; (ii) alginate encapsulation of meristems 
in which sucrose, or a mixture of glycerol and 
sucrose are preloaded; (iii) cryoprotection with 
PVS2; (iv) direct immersion in LN; (v) 
rewarming of the alginate encapsulated 
meristems at 35-45°C; (vi) removal of PVS2 and 
replacement with a sucrose unloading solution. 
Each step requires optimizing for species and 
sensitive genotypes. By reducing or removing 
dehydration and desiccation steps, 
encapsulation-based cryopreservation becomes 
more amenable to desiccation-intolerant plant 
tissues (127, 128). The encapsulation-
vitrification protocol also allows the efficient 
processing of large numbers of plant meristems 
by eliminating lengthy dehydration and 
desiccation treatments. The method has been 
applied across diverse plant taxa (44, 128) and is 
particularly useful for species that are 
recalcitrant to traditional cryopreservation 
methods (103). Adaptations of the basic 
encapsulation/vitrification protocol combined 
with passive, controlled rate cooling have been 
used to cryopreserve plant cell cultures (72).  
 
Alginate-based cryoplate methods 
Yamamoto and colleagues (117, 176, 177) 
developed an aluminium plate (V-cryoplate) 
method for the cryopreservation of plant tissues 
by modifying the PVS2 
encapsulation/vitrification approach of Sakai et 
al., (128). Two types of cryoplates, with 
different dimensions, each with 10 wells to 
accommodate shoot meristems were designed to 
fit into 2 ml cryotubes. In brief, the method 
involves: (i) pouring sodium alginate 
supplemented with sucrose into the wells; (ii) 
placing precultured shoot tips into each well, 
ensuring that they are fully submersed in the 
alginate; (iii) dispensing CaCl2 supplemented 
with sucrose, drop-wise on the shoot-
tips/alginate solution and waiting to achieve 
complete polymerization; (iv) removal of excess 
CaCl2 from the wells; (v) loading the cryoplate 
and the alginate/shoot tip wells with a 
glycerol/sucrose osmoprotectant loading 
solution; (vi) removal of the loading solution 
and replacement with PVS2 cryoprotectant; (vii) 
transfer of cryoplates to cryotubes and direct 
immersion in LN; (viii) retrieval of the 
cryotubes from LN; (ix) immersing the 
cryoplates in sucrose unloading solution and 
rewarming at room temperature; and (x) transfer 
of the shoot-tips to culture medium for recovery. 
Each step of the protocol is optimized for 
specific species and genotypes. The V-cryoplate 
modification was implemented to improve the 
standardization of the encapsulation/vitrification 
protocol for large-scale cryopreservation in plant 
genebanks (117, 176). This method has also 
been adapted for encapsulation/dehydration 
using silica gel and drying beads for the 
cryopreservation of protocorms of Arundina 
graminifolia (30). 
 
3. ALGINATE ENCAPSULATION FOR 
THE CRYOPRESERVATION OF ALGAE 
Alginate is produced by all brown algae 
which can comprise up to 40% alginate (dry 
weight basis); commercial alginates are mainly 
extracted from the genus Laminaria (100). The 
immobilization of algae in alginate has well-
established applications in biotechnological 
metabolite production (146) as well as 
environmental pollution and aquatic research. 
Alginate gels used in combination with silica 
matrices have been tested as biocompatible 
structures for creating portable microcosms 
comprising different assemblages of organisms, 
including microalgae (111). The advantages of 
immobilizing algal cells in alginate are null 
toxicity, protection from deleterious physical 
and chemical changes, gel permeability, 
convenient addition and release of metabolites 
and visual transparency (100). Calcium alginate 
encapsulation has been used for the medium-
term storage of microalgae in culture collections 
(29). 
 
Development of alginate-based cryostorage 
methods in algal culture collections  
Cryopreservation is used for the long-term 
stabilization of algal culture collections (35) for 
which controlled rate cooling in combination 
with cryoprotective additives is the usual method 
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of choice (160). Alginate encapsulation has been 
pioneered as an alternative approach especially 
for species and strains that are recalcitrant to 
traditional cryostorage protocols (55, 63). Hirata 
et al. first tested encapsulation/dehydration for 
the cryopreservation of Dunaliella tertiolecta 
and subsequently used the method to 
cryopreserve six marine microalgae, one 
freshwater microalga and four strains of 
freshwater cyanobacteria (63). The protocol was 
adapted from that developed for plants and, in 
brief, involves: (i) encapsulating microalgae in 
sodium alginate polymerized with CaCl2; (ii) 
osmotically dehydrating the cells with sucrose at 
an optimal level and duration of exposure; (iii) 
bead desiccation in a cultivation chamber to a 
dehydrated bead weight of 30% of the initial 
fresh weight; (iv) direct immersion in LN; (v) 
rewarming at 37˚C in a water-bath; and (vi) 
post-storage cultivation using standard methods 
and optimal light regimes.  
Vigneron et al. (1997) applied 
encapsulation/dehydration for cryopreservation 
of gametophytes of the marine alga Laminaria 
digitata (168). The encapsulated gametophytic 
cells were pretreated for 6 h in liquid medium 
containing 0.3 - 0.5 M sucrose to within the 
range of 70 - 90% (fresh weight) followed by 
desiccation in a sterile laminar air flow. Cooling 
was undertaken in two steps, the first involved 
slow cooling from 19˚C to -40˚C and direct 
immersion into LN. The beads were rewarmed 
in a water-bath at 40˚C and recovery time was 2 
weeks (168). Encapsulation/dehydration with or 
without two-step cooling was initially applied 
with some success for the cryopreservation of E. 
gracilis (34). This method was subsequently 
explored by Harding et al. (55, 58) for the 
cryopreservation of a wider taxonomic range of 
microalgae that were unresponsive to controlled 
cooling protocols. The general procedure for the 
encapsulation-based cryopreservation of algae is 
similar to that applied to plants and has the 
advantage of being amenable to culture 
collections that do not have access to cooling 
equipment. Rewarming can be conveniently 
undertaken at ambient temperatures in a laminar 
air flow hood followed by rehydration of the 
beads in liquid medium to remove sucrose, 
before transfer to recovery medium. The 
dissolution of alginate beads using the detergent 
sodium hexametaphosphate may be required so 
that cells and organisms can be released, recover 
and replicate (81). Na-alginate does not dissolve 
effectively in sea or salt water and caution is 
required during intended bead dissolution as 
sodium hexametaphosphate is a powerful 
antisalination agent which can interfere with 
seawater-based media used to culture marine 
organisms (100). The potential of using 
alginate/encapsulation for the cryopreservation 
of recalcitrant algae has been tested for 
Porphyridium aerugineum (2). The 
cryopreservation of the marine diatoms 
Nitzschia closterium f. minutissima and 
Chaetoceros muelleri using 
encapsulation/vitrification has been investigated 
by Zhang et al. (181) who demonstrated that 
optimal PVS2 loading of alginate beads 
supported the highest post-cryopreservation 
viability of ~74% for Nitzschia closterium. 
Kumari et al. (76) improved recovery of 
Oocystis spp. and Anabaena spp. using an open 
encapsulation/PVS2 vitrification system in 
which samples are directly exposed to LN rather 
than being enclosed in a cryovial. The addition 
of antioxidants 2-mercaptoethanol and 
glutathione on post-warming improved the 
viability of algae in both open and closed 
systems.  
 
Validation and quality management of 
encapsulation-based protocols in algal 
cryobanks  
The alginate/encapsulation protocol has 
been successfully applied by European culture 
collections for the cryopreservation of a diverse 
taxonomic range of microalgae (36, 43, 55, 58, 
81).  
Figure 3 demonstrates the application of 
alginate encapsulation for the cryopreservation 
of microalgae held by the culture collection of 
the Sammlung Von Algenkulturen, Universitat 
Gottingen (SAG), Germany. The duration of 
exposure to evaporative air desiccation, the use 
of silica gel and the dark/light conditions applied 
in the initial post-storage recovery period was 
found to be critical for the survival of some 
species (58).    
The large-scale cryopreservation of diverse 
algal taxa in culture collections (Fig. 3) has been 
supported by international networking and 
European infrastructures projects that have 
focused on cryobank methods validation and 
quality management (10, 36). These resulted in 
alginate-based methods being validated and 
deployed across a range of taxa maintained in 
European algal culture collections (43, 58, 81). 
The verification of identity and genetic stability 
in cultures recovered from algae cryopreserved 
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using both traditional and alginate-based 
protocols also has been undertaken as a quality 
assurance measure (57, 101). 
As culture collections continue to underpin 
algal biotechnologies, environmental science 
and research it will become increasingly 
important to develop robust quality management 
systems for algal cryobanks. Bui et al. (23) 
caution that although the mechanisms 
underlying algal cryopreservation are generally 
understood the impacts of the many technical 
variations in storage protocols reported in the 
literature are not always elaborated, making it 
difficult to optimize and standardise protocol 
variables to maximise post-storage recovery 
(Fig. 3). To address this issue a new approach to 
biopreservation quality management the 
Standard PRE-analytical Code (SPREC) which 
was first developed for clinical biobanks (14) 
has been adapted for algal culture collections. A 
prototype SPREC which systematically 
annotates and documents the variables to which 
algal cultures are exposed during culture and 
cryopreservation has been constructed for 
microalgae (10). The code includes all possible 
permutations of cryopreservation variables 
including those incorporating alginate 
encapsulation; the algal SPREC has the 
flexibility to be expanded as new protocols and 
modifications to existing protocols are 
developed. Bui et al. (23) suggest that the 
examination of key variables in algal 
cryopreservation is necessary to make further 
improvements possible and that a more 
comprehensive investigation of these variables is 
of interest. This concept concurs with the recent 
development of new reporting procedures and 
standards for biodiversity biobanks and 
collections which involves sample reporting and 
biopreservation process chain variable 
annotation (11). 
 
4. ALGINATE-BASED CRYOBIOLOGY 
FOR PHYTODIVERSITY 
CRYOPRESERVATION  
The cryoprotective modality of alginate 
cryopreservation as applied to cyanobacteria, 
algae and plants is vitrification, various 
treatment combinations can be applied to create 
the glassy state including: evaporative 
desiccation using air or chemical desiccants such 
as silica gel; osmotic dehydration treatments 
(e.g., sugars, alcohols, polyols) combined with 
alginate bead encapsulation and evaporative 
desiccation (encapsulation/dehydration) or the 
applications of chemical cryoprotectants 
combined with alginate bead encapsulation 
(encapsulation-vitrification). Vitrification 
treatments impose extreme biophysical and 
chemical stress that can be detrimental to plant, 
algal and cyanobacterial cells, therefore tissues 
of less tolerant plant species are usually 
acclimated before they are cryopreserved. Two 
acclimation strategies are used: 1) exposure to 





Figure 3. Micrographs representative of typical regrowth responses from alginate 
encapsulated cryopreserved SAG strains of microalgae: (A) Parachlorella kessleri SAG 211-
11g and (B) Chlorella trebouxioides SAG 3.95 following encapsulation, dehydration and 
exposure to different desiccation treatments. Reproduced with permission from CryoLetters 
[Harding et al. (58). SAG = Sammlung Von Algenkulturen, Universitat, Gottingen, Germany.  
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pregrowth additives (e.g. sucrose, mannitol, 
sorbitol) that simulate seasonally-induced cold 
acclimation in dormant tissues (9, 122, 141) or 
2) exposure to cold hardening treatments (121). 
Cold hardening was found to improve the 
recovery of pear shoot meristems cryopreserved 
using encapsulation/dehydration (39, 136) and 
the same approach has been successfully 
incorporated into alginate-based protocols for a 
wide range of plant species (119). To achieve 
the best possible post-storage recovery the 
optimization of all stages of encapsulation 
protocols may be necessary for certain species 
and genotypes (9, 55, 114). Usually alginate 
encapsulated cells and tissues are cooled at ultra-
high rates by direct exposure to LN, although in 
the case of microalgae controlled, two-step 
cooling can be combined with encapsulation and 
chemical cryoprotection (9, 35, 55). 
 
Alginate vitrification, critical factors and Tgs 
Cryopreservation involving encapsulation/ 
dehydration and encapsulation/vitrification 
involves a change in state from a liquid to a 
glass, which is defined by a characteristic glass 
transition temperature (Tg). As glasses are 
metastable the stabilization of the thermal 
properties of alginate is crucial for post-storage 
recovery (9). Differential scanning calorimetry 
(DSC) elucidates the physical thermal 
parameters (freezing, melting, Tgs) that are 
critical for the survival of cryopreserved 
encapsulated tissues thus thermal analyses can 
be used to optimize cryopreservation protocols. 
In alginate encapsulated tissues thermal stability 
corresponds to a critical moisture content (MC) 
that must be achieved to prevent the formation 
of ice during cooling and rewarming, the latter 
being particularly important as glass relaxation 
and devitrification can result in the formation of 
lethal ice (12). Glasses created using alginate 
encapsulation/dehydration remain stable on 
passive rewarming at ambient temperatures so 
long as a critical lower MC is obtained during 
desiccation, in contrast vitrification solutions 
require optimal rewarming to avoid 
devitrification, glass fracturing and ice 
nucleation (12). As glass stability is dependent 
upon a crucial water content it is important to 
calibrate osmotic dehydration and desiccation 
treatments with survival. Using DSC, Benson et 
al. (8) found that encapsulated/air desiccated 
Ribes shoot meristems had stable Tgs on cooling 
and rewarming (at around -68°C and -60°C 
respectively) for a MC of ~25% (fresh weight 
basis). These thermal analyses were used by 
Block (16) and Benson et al. (12) to verify 
critical factors in alginate bead preparation; thus, 
stable glass formation on cooling and rewarming 
required a bead water content of 0.4 g water g-1 
dry weight which corresponded with ~26% MC 
on the basis of fresh weight. In high humidity 
environments silica gel treatments are preferred 
to assure consistent desiccation. Under these 
conditions Sherlock et al. (143) revealed Tg 
profiles for encapsulated/dehydrated Ribes of     
-78°C to -51°C (cooling) and -88°C to -4°C 
(warming) at ~0.3 to 0.4 g water g-1 dry weight. 
Using DSC, Dumet et al. (42) studied the 
stability of different components of 
encapsulated-dehydrated Ribes shoot-tips and 
revealed minor thermal events on warming that 
were indicative of glass destabilization. 
However, this did not occur in the alginate or the 
Ribes shoot meristems when they were cooled 
and rewarmed separately. It might be expected 
that alginate encapsulated cells vitrified at very 
low water contents will have fewer, less mobile 
water molecules that are available to participate 
in nucleation, devitrification and ice growth on 
rewarming (9, 12).  
Understanding the natural mechanisms that 
control desiccation tolerance in plant tissues that 
are sensitive to freezing can provide valuable 
insights into how to develop alginate-based 
cryostorage protocols (12, 141). Thermal 
analysis is a particularly valuable tool for the 
study of cryopreservation in tropical plant 
species that are recalcitrant to cryopreservation 
and for which the success of encapsulation/ 
dehydration or encapsulation/vitrification is 
critically dependent upon achieving MC and 
cellular viscosity at which stable glasses can be 
formed (12). For example, DSC profiles have 
been used to optimize alginate-based treatments 
for the cryopreservation of somatic embryos 
derived from the tropical tree Azadirachta indica 
(12). Similarly, Nadarajan et al. (103) 
constructed thermal profiles for 
encapsulated/vitrified shoot-tips of the 
recalcitrant seed producing tropical leguminous 
tree Parkia speciosa, demonstrating that 
trehalose moderated the thermal behaviour of the 
shoot-tips to favour glass stabilization and 
survival. The combination of alginate 
encapsulation, PVS2 and trehalose had the 
synergistic effect of reducing the molecular 
mobility of water, which may be advantageous 
in recalcitrant, desiccation sensitive tropical 
plant germplasm cryopreservation (103).  
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Once treatments are optimized the glasses 
formed in alginate encapsulated plant cells and 
tissues may be considered to be very stable and 
sucrose dehydration combined with desiccation 
limits the molecular mobility of water in the 
beads. Gonzalez-Arnao and Engelmann (51) 
propose that plant cells and tissues 
cryopreserved using encapsulation/dehydration 
can be rewarmed at ambient temperatures 
without risks of de-vitrification as the samples 
are sufficiently dehydrated to stabilize the glassy 
state. Thermal analysis studies do imply that this 
is the case, as long as treatments achieve a 
critically low, non-lethal MC before cooling and 
rewarming (8, 12). 
Moisture profiles of 
encapsulated/dehydrated, cryopreserved 
microalgae (34, 63, 168) reveal that they are 
outside (ca. > 30% MC on a fresh weight basis) 
or close to the critical MC range usually required 
to form and stabilize the Tgs of 
encapsulated/dehydrated plant tissues (12). On 
cooling and rewarming this may risk 
devitrification in algal cells with the possibility 
of ice being formed at higher moisture levels. 
This may explain why the cryopreservation of 
algae using encapsulation/dehydration requires 
an additional controlled rate cooling step (34, 
168) presumably because cryo-dehydration of 
the remaining water is necessary to achieve a 
stable vitrified state. Harding et al. (55) applied 
DSC to study vitrification in 
encapsulated/dehydrated Euglena gracilis, 
revealing a Tg at -75°C on cooling in cells that 
had been dehydrated in sucrose and air 
desiccated for 3 h to a residual MC of 25% 
(fresh weight). In contrast, Hirata et al. (63) 
demonstrated the survival of several species of 
encapsulated algae and cyanobacteria without 
the need for controlled rate freezing to be 
applied after the encapsulation/dehydration.  
Clearly alginate encapsulation as applied to 
phytodiversity cryopreservation has promising 
future applications, although progress to date has 
been advanced mainly through empirical 
research. Future developments will require a 
greater fundamental knowledge of cryobiology 
and the stress physiology that underpins 
alginate-based cryopreservation and an 
understanding of natural adaptations to cold 
stress as well as those incurred during 
cryostorage (9, 12, 55, 141).  
  
 
5. ALGINATE ENCAPSULATION FOR 
FUNGAL CRYOSTORAGE 
Methods of encapsulation have been used 
to entrap microorganisms for many years. 
‘Immobilised’ fungi have been used by the 
biotechnology industry to produce novel 
products and commercial enzymes (78), for 
formulation of biological control agents (32, 
110), for carriers of mycoherbicides (169) and as 
sources of inocula for ecomycorrhizal fungi 
(95). However, unlike other cell types, alginate 
encapsulation has not been widely adopted for 
the cryopreservation of fungi. This is primarily 
because the majority of filamentous fungi can be 
preserved using standard approaches to 
cryopreservation that involve the application of a 
controlled cooling rate in association with an 
appropriate cryoprotectant, typically 1°C min-1 
with 10% glycerol solution (126). Further, for 
most culture collections, encapsulation is 
significantly more laborious than traditional 
cryopreservation approaches and the need for 
sterility is imperative as the perceived increased 
risk of sample contamination due to the many 
manipulative steps that are involved in the 
encapsulation process. For cryopreservation 
recalcitrant fungi and the heterotrophic 
filamentous chromists, alternative approaches 
are required, and there have been several reports 
of encapsulation being utilised for this purpose.  
A basic encapsulation approach was used for the 
preservation of the dry rot fungus Serpula 
lacrymans (125). This economically important 
basidiomycete fungus is notoriously difficult to 
maintain. Like other basidiomycetes it is only 
the ‘mycelial’ state that can be preserved and 
this state is susceptible to ice damage during 
cryopreservation. Although, the alginate beads 
were not subject to dehydration, the author 
found that encapsulation in calcium alginate 
significantly improved post-storage viability. A 
more advanced encapsulation/dehydration 
approach was used by Wood et al. (172) for the 
simultaneous preservation of orchid seed 
(Dactylorhiza fuchsia and Anacamptis morio)  
and its fungal symbiont  (Ceratobasidium 
cornigerum). After encapsulation, the biological 
material was subjected to pretreatment with 
sucrose and subsequent drying before 
cryopreservation. It was found that embryo 
growth of both orchids and fungal development 
were not detrimentally affected when the beads 
were pre-dried to ca. 20% MC with viability of 
the seed and the fungus remained unchanged 
during 30 days storage at -196°C. The results 
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indicated opportunities for utilising both 
simultaneous cryopreservation and 
encapsulation as a conservation tool for diverse 
taxa and has since been used for other terrestrial 
orchid relationships (147). Cryopresevation of 
arbuscular mycorrhizal fungi is also 
problematical. Unlike filamentous fungi, many 
mycorrhizal fungi cannot be cultured in vitro, so 
researchers have turned to alginate encapsulation 
approaches (79, 80)  as this has the added 
advantage in that it can be used as a direct 
source of inoculum (151).  
Despite success with mycorhizza, there are 
very few published reports about the use of 
encapsulation for cryopreservation of 
filamentous fungi. However, a more in depth 
study was undertaken, where an encapsulation 
vitrification protocol was trialled across five 
European Culture Collections (3). The protocol 
was based on a regime originally developed for 
microalgae through the EU Cobra project (57) 
and was modified for use with fungi. A suite of 
representative fungi from the taxonomic groups 
Zygomycota, Basidiomycota, Ascomycota and 
some heterotrophic chromists were selected and 
then encapsulated using a technique which 
involved encapsulation of mycelium into 
calcium alginate, stepwise dehydration using 
sucrose gradient solutions and air drying, before 
plunge cooling in LN. The study also compared 
the genetic stability of samples subjected to 
encapsulation with those subjected to standard 
cryopreservation approaches. It was found that 
for most fungi, encapsulation-vitrification 
cryopreservation can produce viable, 
morphologically ‘typical’ cultures, therefore 
negating the need for control rate cooling. 
However, some evidence of genetic instability 
was detected and this warranted further 
investigation. Of particular note was the 
successful encapsulation and recovery of the 
heterotrophic chromists Phytophthora 
citrophthora and Saprolegnia diclina (71, 144). 
Heterotrophic  chromists are members of the 
Stramenopila and are particularly vulnerable to 
ice damage as the mycelial filaments are 
aseptate. When subjected to traditional 
cryopreservation regimes, ice seeds down the 
hypha, thus the removal of water during the 
encapsulation-vitrification procedure negates the 
prospects of lethal ice formation. 
While osmotic dehydration is the standard 
approach for fungal encapsulation 
cryopreservation, some workers advocate 
omitting a stepwise dehydration approach and 
simply suspending beads in cryoprotectants such 
as glucose and lactose. This was applied to 
strains of Malassezia spp. and the zygomycetes 
species Rhizopus and Mucor. It was concluded 
that the use of 23% glucose or lactose at -80°C 
in a sodium alginate cell immobilisation system 
is efficient for cryopreserving zygomycetes, 
although Malassezia spp. did not survive beyond 
(124). 
There is still much potential for the 
application of encapsulation dehydration 
techniques to cryopreservation recalcitrant fungi 
and heterotophic chromists and related 
organisms, particularly those susceptible to ice 
damage. The method may also be useful for 
preservation strategies for the microbiome and 
has an application in laboratories that do not 
have access to controlled rate cooling 
equipment. 
 
6. ALGINATE ENCAPSULATION 
CRYOPRESERVATION APPLIED TO 
ANIMAL AND HUMAN CELLS 
The development of AECryo in animal and 
human cells in some ways mirrored the progress 
made in plant cell technologies, but arrived some 
10 years later. Alginate encapsulation was 
indeed under study in animal cell fields by the 
late 1980’s, but from a different perspective – 
the use of the biocompatible hydrogel to prevent 
immune rejection of transplanted animal cells 
such as Islets of Langerhans or hepatocytes in 
cell transplant models (22, 97, 107). In these 
situations, the alginate hydrogels were found to 
allow diffusion of small molecules and 
metabolites into and out from the transplanted 
cells, which could be taken as an early pointer 
that for cryopreservation, the necessary 
movement of cryoprotectants and water should 
also be achievable. Pursuing these ideas, Woods 
and colleagues (173) undertook experiments to 
compare cryoprotective additive (CPA) 
permeation into human Islets of Langerhans 
either indirectly or after prior alginate 
encapsulation.  Results indicated that there were 
small but important differences in CPA 
permeation parameters, which should be taken 
into account when applying AECryo.  
In the cell transplantation field, several 
applications combined alginate with secondary 
agents such as poly-L-lysine and chitosan for 
improving stability of the supporting hydrogel 
matrix (54, 107, 112).  Islets remained a focus of 
attention and it was shown that rat Islets could 
be cryopreserved using DMSO, AECryo with 
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alginate – poly-L-lysine and slow cooling 
approaches, with a subsequently good function 
demonstrated as in vitro release of insulin to a 
glucose challenge (26).  Alongside the interest in 
animal cell biotechnology, AECryo was applied 
for cryopreservation of stably transfected human 
kidney cells, again using DMSO and slow 
cooling (150). Flow cytometry revealed no 
AECryo induced changes in cell ploidy with a 
good recovery of therapeutic protein synthesis 
following thawing.  Application of AECryo to 
both primary rodent hepatocytes or to an 
immortalised human liver cell line using 
standard slow cooling techniques was equally 
successful (86), with improved survival in a rat 
model of fulminant liver failure after 
transplantation of thawed encapsulated liver 
cells.  Similarly, long-term storage of AECryo 
rat hepatocytes was shown to be compatible with 
maintenance of drug transporting properties 
(73).  For the majority of animal cell studies, 
alginate encapsulation required to produce beads 
with diameters within the range 200–400 µm, 
with alginate concentrations between 1–2% w/v. 
For example, for AECryo of porcine primary 
hepatocytes, 400 µm alginate – poly-L-lysine 
beads were used to reverse fulminant hepatic 
failure in a mouse model system (98). Again, 
application of slow cooling with CPA DMSO 
was found to be successful when transplanting 
the thawed, bead-encapsulated hepatocytes.  
Further studies on AECryo of rat and porcine 
Islets of Langerhans compared alginate – poly-
L-lysine and alginate – protamine heparin beads, 
with slow cooling and DMSO system. 
Cryobanking was carried out for > 400 days in 
some cases, whilst post-thaw recoveries were 
higher when alginate encapsulated Islets were 
compared with non-encapsulated cells (5).   
Reports of successful cryopreservation of Islets 
applying AECryo and standard slow cooling 
protocols continue to be published (135), with 
certain refinements such as AECryo of single 
Islet containing beads (28), which can improve 
the understanding of robust numerical cell 
recovery data post cryopreservation, which can 
be difficult when multiple cell numbers have 
been encapsulated at the start of the process.    
Reproductive cryobanking of animal or 
human cells is one of the largest end users of 
cryostorage. Within that discipline, interest in 
AECryo has also recently developed.  Song and 
colleagues (148) discussed the possible benefits 
of encapsulation strategies in their review on 
future developments in cryopreservation in 
reproductive medicine. The possibility of 
applying AECryo techniques for 
cryopreservation of sex sorted semen has 
recently been discussed (149).  The concept of 
alginate encapsulation to support the in vitro 
growth of isolated follicles from human ovarian 
tissue has also recently been discussed (178), but 
cryopreservation has not yet been reported.  
Similarly, alginate encapsulation with growth 
factor-laden nanoparticles has been suggested to 
improve graft success of mouse immature 
testicular tissues (134, 135) after initial tissue 
cryopreservation, but again AECryo as a discrete 
step has not yet been reported. It is likely that 
AECryo will become more widely applied in 
reproductive cryopreservation in the future.   
 
Alginate encapsulation for mammalian stem 
cells  
Since 1964, when Thomas M. S. Chang 
developed a method for microencapsulation of 
biological material in natural polymers (25), cell 
microencapsulation in alginate has been widely 
investigated mainly in the field of 
transplantation, because the semi-permeable 
alginate matrix protects encapsulated cells from 
the host immune system. It also came to be 
understood that alginate encapsulation could 
offer advantages for manipulating cells 
undergoing cryopreservation. The approach 
seems to be feasible for allogenic and xenogenic 
transplantation of encapsulated cells. However, 
the number of primary, usually terminally 
differentiated cells, sufficient for therapeutic 
efficacy, is limited by the complexity of the 
isolation procedures and donors’ organ 
availability. Therefore, an attractive alternative 
is stem cells due to their ability for self-renewal 
and multilineage differentiation. Stem cells are 
now found in nearly all tissues throughout the 
body, their properties are well characterized and 
by differentiation capacity they may be 
classified as pluripotent or multipotent.  
Pluripotent stem cells 
Pluripotent stem cells include embryonic 
stem cells (ESCs), derived from the inner cell 
mass of the pre-implantation blastocyst (46, 
161), germ stem cells (GSC) derived from 
primordial germ cells that arise in the late 
embryonic and early fetal period of development 
(142) and induced pluripotent stem cells 
(iPSCs), obtained by reprogramming somatic 
cells to a pluripotent state (153). All these 
pluripotent stem cells can expand indefinitely in 
26 
 
vitro and differentiate into all three germ 
lineages, consequently giving rise to cells from 
all tissue types. ESCs, GSCs and iPSCs 
demonstrate similar phenotype, growth and 
differentiation patterns. So, results obtained on 
one type of cells can be easily translated to all.  
Numerous studies have demonstrated that 
two-dimensional (2D) culture systems routinely 
used for expansion of these stem cells do not 
adequately simulate the in vivo 
microenvironments of stem cell niches (82) and 
limit the control of cell growth and 
differentiation from external sources. Moreover, 
pluripotent ESCs expanded in 2D culture 
systems show low cell recovery yields and high 
rates of uncontrolled differentiation were 
obtained after conventional slow-cooling 
cryopreservation protocols (60). In comparison 
with the low survival rates obtained with slow-
cooling cryopreservation, vitrification protocols 
provide higher cell viability, particularly 
regarding murine ESCs (83, 180). These 
limitations have resulted in low production 
yields and have stimulated the development of 
efficient, scalable and cost-effective stem cell 
expansion processes (113).  
Development of 3D systems for expansion 
of human ESCs as aggregates or after 
immobilizing them on microcarriers, in 
combination with usage of bioreactors, has 
provided the possibility to obtain homogenous 
cultures and enhance cell recovery yields (70, 
139). Alginate microcapsules can be considered 
as a 3D specific microenvironment for 
pluripotent stem cells supporting cell 
proliferation and control of differentiation from 
the external environment. ESCs encapsulated in 
1.1% alginate hydrogels retained their 
pluripotency without passaging or embryoid 
body formation during culture in basic medium 
for a period of up to 260 days and could 
differentiate when they were subsequently 
cultured in a conditioned environment (145). 
Moreover, encapsulation in alginate enhanced 
the differentiation of ESCs into hepatocytes 
(83), insulin-producing cells (170), cardiac cells 
(69), retinal and neuronal lineages (37, 66).  In 
addition, alginate encapsulated pluripotent stem 
cells are more resistant to mechanical forces 
taking place in stirred tank bioreactors. 
Cryopreservation of ESCs as single cells, 
aggregates or immobilized on microcarriers has 
been the subject of many reports, and their 
results well analyzed in reviews (65, 99). In 
some respects, cryopreservation of alginate 
encapsulated pluripotent stem cells is still poorly 
investigated, while cryopreservation can be easy 
integrated into the total biotechnological 
process, included expansion, cryopreservation 
and rehabilitation of cells after rewarming.  A 
mathematical model which couples the mass 
transport of DMSO into a cell-seeded spherical 
construct and cell membrane transport into ESCs 
was applied to predict overall cell survival rate 
after conventional cryopreservation (130). 
Predicted results were confirmed by the 
experimental data which show survival of about 
60% after rewarming of murine ESCs 
cryopreserved using -1°C per min slow-rate 
cooling with 10% DMSO as CPA within 1.2 mm 
alginate capsules. Cryopreservation under the 
same conditions using murine ESCs within 
adhesive alginate microcapsules, where alginate 
was modified by coupling arginine-glycine-
aspartic acid-serine (RGDS) providing cell 
attachment to the substratum, led to even more 
encouraging results (129). Cells cryopreserved 
in RGDS-alginates had survival of 93±2% 
(trypan blue exclusion assay), and significantly 
higher metabolic rates than both cells 
cryopreserved in suspension and those 
encapsulated in unmodified alginate. After 
rewarming murine ESCs cryopreserved in 
RGDS-modified alginate microspheres 
maintained the expression of stem cell markers 
and pluripotency assessed by differentiating 
them along the three lineages. 
However, conventional cryopreservation of 
human ESCs demonstrated less optimistic 
results. In one study (90) a comparative 
evaluation of different procedures of slow-rate 
cooling for cryopreservation of intact, adherent 
human ESCs as colonies or clumps entrapped in 
alginate has been carried out. Conventional 
cryopreservation with 10% DMSO included 
slow-rate cooling in three different media, which 
resulted in extensive loss of membrane integrity 
and metabolic activity within 24 h post-
rewarming.  No additional cryoprotective effect 
was observed when the apoptosis inhibitors Z-
VAD-FMK or/and ROCK inhibitor Y-27632 
were added either to the cryoprotective medium 
or after rewarming. Alginate encapsulation did 
not provide further protection to low-rate cooled 
ESCs as either colonies or clumps. Although 
reduced cell detachment from the culture surface 
for alginate encapsulated ESCs colonies was 
observed immediately after thawing, within 24 h 
all cells presented damaged membranes 
regardless of the alginate entrapment. In another 
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study by Serra et al. (140) ESCs were 
microencapsulated in alginate microspheres with 
a diameter of approximately 500–700 µm as: i) 
single cells; ii) aggregates; and iii) immobilized 
on Cytodex microcarriers coated with Matrigel 
as previously has been reported by Nie et al.  
(104). After conventional cryopreservation in a 
medium containing 10% DMSO using a low rate 
(-1˚C/min) cooling protocol, storage in the gas 
phase of a LN, rapid warming and stepwise 
washing out DMSO, ESCs were cultured for the 
next 9 days. Results showed that in aggregate 
culture, alginate microencapsulation did not 
prevent cell death immediately after rewarming. 
On the contrary, microencapsulated ESCs 
immobilized on microcarriers presented higher 
cell viabilities and cell recoveries after 
cryopreservation. These results indicate that for 
the cryopreservation of alginate encapsulated 
human pluripotent stem cells, the conventional 
slow cooling protocols should be further 
optimized. 
 
Multipotent stem and progenitor cells   
Multipotent stem cells have more limited 
self-renewal and differentiation capacity than 
pluripotent stem cells; usually multipotency is 
restricted to producing the differentiated cell 
types of the tissue in which they reside. 
Common multipotent stem cells include neural 
stem cells (NSCs), mesenchymal stem/stromal 
cells (MSCs) and hematopoietic stem cells 
(HSCs). NSCs have specific phenotypes and are 
able to differentiate into neurons, astrocytes, 
oligodendrocytes and microglia (131, 138). In 
culture NSCs proliferate forming non-adherent 
clusters named neurospheres. As a source of 
NSCs for research and cell based therapy, 
neurospheres have been a subject of numerous 
multidisciplinary studies, including cryobiology. 
Nevertheless, there is only one report aimed at 
the development of a strategy for neurosphere 
cryopreservation using alginate encapsulation 
(89). Neurospheres prepared from fetal rat brain 
were encapsulated at the 5th day of culture and 
cryopreserved at day 19. Alginate encapsulation 
prevented fusion of small neurospheres and did 
not affect the viability, proliferation and 
glycolytic metabolism of the cells or the 
development of neurospheres during pre-
cryopreservation culture. Alginate encapsulated 
and non-encapsulated neurospheres were 
equilibrated in a cryopreservation solution 
containing 10% DMSO for 30 min at 4°C. 
Samples were cooled at -1°C/min to -80°C, then 
stored in the vapor phase of LN for 1–2 weeks. 
It was shown that cryopreservation of non-
encapsulated neurospheres resulted in loss of 
spherical shape and cell disintegration. For 
encapsulated neurospheres, no significant 
fragmentation or loss of spherical shape was 
observed after cryopreservation. Cell survival of 
both encapsulated and non-encapsulated 
neurospheres was high immediately post-
warming and decreased after the first 24 h of 
culture. Subsequently alginate encapsulated 
neurospheres were able to recover during post-
rewarming culture and maintain capacity for 
neuronal and glial differentiation.    
Mesenchymal stem/stromal cells (MSCs) 
can differentiate into cells of bone, cartilage, 
muscle, fat and other tissues, which makes them 
attractive for regenerative medicine and tissue 
engineering. MSCs are adherent cells and in 
monolayer culture they grow as flat colonies of 
fibroblast-like cells. Alginate has weak adhesive 
properties and after encapsulation in alginate 
hydrogel MSCs become round-shaped and 
reversibly stop proliferating (115). 
Successful cryopreservation of alginate 
encapsulated MSCs provides cryobanking of the 
cells and allows to avoid cell aging, and prevent 
loss of their ability to perform multilineage 
differentiation. In a recent report (115) human 
bone marrow MSCs, either encapsulated in 
alginate microbeads  with sizes over the range of 
500-1000 µm or as cells in suspension, were 
cryopreserved with 5% and 10% DMSO using 
conventional 2-step slow cooling (protocol 1). 
The viability and metabolism of MSCs in 
alginate microbeads following cryopreservation 
with 5% DMSO were lower than those 
cryopreserved with 10% DMSO. MSCs in 
suspension were more resistant to 
cryopreservation than alginate encapsulated cells 
when cryopreserved with 5% DMSO, although 
when using 10% DMSO, no differences were 
detected. Comparison of the viability and 
metabolic activity of MSCs cryopreserved either 
in alginate or as cell suspensions with 10% 
DMSO using protocol 1 (2-step cooling), 
protocol 2 (3-step slow cooling with induced ice 
nucleation) or protocol 3 (rapid 1-step cooling), 
showed that the highest viability and metabolic 
rates were obtained following cryopreservation 
of MSCs in alginate microbeads by protocol 2 
(with controlled ice nucleation) (115). After 
cryopreservation by protocol 2, alginate 
encapsulated MSCs were capable for 
multilineage differentiation towards osteogenic, 
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adipogenic and chondrogenic lineages. Positive 
effects of initiation of ice crystallization can be 
explained by removal of critical supercooling 
events, which may negatively impact on the 
MSCs in alginate microbeads during slow 
cooling. This strategy has been successfully used 
for cryopreservation of alginate encapsulated 
chondrocytes (1), and transformed human 
embryonic kidney cells (150) and liver cells 
(93). Results similar to the ice seeding effect 
were obtained after reduction of the cooling rate 
to 0.5°C/min. In this case survival of human 
dermal MSCs after cryopreservation with 7.5% 
DMSO within alginate microbeads was 81 ± 4% 
and did not differ from that in suspension (157). 
The difference in DMSO concentrations (10% 
and 7,5%) used in the studies (115, 157) was 
obviously not important, because in another 
report (52) it has been shown that MSCs derived 
from common marmoset monkey and 
encapsulated in alginate beads could be 
cryopreserved with equal efficiency using slow-
cooling protocol with 7.5% and 10% DMSO as a 
cryoprotectant. 
Results on human and primate MSCs do 
not confirm the positive opinion of the 
cryoprotective properties of alginate hydrogel 
obtained for example during rapid cooling of 
encapsulated hepatocytes (6, 77). 
Cryopreservation of human MSCs with rapid 
cooling even with 10% DMSO resulted in 
critical damage to the encapsulated MSCs (115). 
Moreover, after rapid cooling, changes in the 
structure of the alginate gel have been observed, 
which were reflected in a loss of transparency 
and shape of the alginate microbeads; these 
effects may have resulted from growth of ice 
crystals within the polymer gel matrix during 
rapid cooling. Similar responses of alginate 
microbeads’ integrity and encapsulated therein 
CV1 line cells during either rapid or slow 
cooling were described by Heng et al. (61).  
The integrity of alginate beads during rapid 
cooling is a requirement for the successful 
cryopreservation of alginate encapsulated cells 
via vitrification where outcomes, besides general 
conditions such as cooling rate and sample 
volume, will depend on microbeads’ size and 
composition. For example, rapid-cooling 
cryopreservation protocols included plunging the 
cryovials with cells encapsulated in 300-400 µm 
alginate microbeads with high DMSO 
concentrations (3.5-4.5 M) directly into LN and 
did not enable completely the prevention of  
microbead disruption and also resulted in low 
post-warming cell viability (<10%) (61). In 
addition, inclusion of 0.25 M sucrose or 20% 
Ficoll did not significantly improve neither post-
warming cell viability nor microcapsule 
integrity. On the other hand, vitrification in 
small (~100 μm) alginate microbeads using 400 
μm quartz microcapillaries resulted in their post-
warming intactness in the presence of 1.5 M or 
higher  DMSO concentrations (181). Mouse 
MSCs encapsulated in small alginate microbeads 
and derived from mouse embryos had 2-times 
higher post-warming survival than non- 
encapsulated cells (89±3% and 42±4%, 
respectively). In the later report by Huang et al.  
(64) vitrification of murine ESCs and human 
adipose-derived MSCs encapsulated into small 
alginate microbeads (~220 μm) using small 
sample volume (<2.5 μl) and correspondently 
high cooling/warming rates in culture medium 
with 1.3 M trehalose and 2 M 1,2-propanediol as 
the non-penetrating and penetrating CPA, 
respectively, compromised neither microbead 
integrity nor the specific functional properties of 
the cells assessed by expression stem cell 
markers and their differentiation ability (64). 
Moreover, the authors revealed that alginate 
hydrogel microencapsulation could effectively 
inhibit devitrification during warming, thus 
reducing concentrations of required penetrative 
cryoprotective agents. However, the vitrification 
protocol in small microbeads and in small 
sample volumes has not yet been performed for 
the practical application to bank stem cells 
where large volumes are often preferred. 
Vitrification of human MSCs in large 
alginate microbeads with sizes over the range of 
1100-1200 μm in 0.5 ml of multicomponent 
vitrification solution (VS) comprised of 10% 
DMSO, 20% ethylene glycol, 20% 1,2-
propanediol and 0.5 M sucrose using standard 
cryovials was studied (164). High post-warming 
viabilities, metabolic activity and two-lineage 
differentiation processes of MSCs comparable 
with non-encapsulated cells (and without loss of 
microbead integrity) was achieved after the 
significant extension of exposure time to the 
cryoprotective agents. Successful vitrification of 
porcine MSCs in large (800-1000 μm) alginate–
fibrin microbeads has been achieved in a 
minimal volume of VS composed of 40% 
ethylene glycol and 0.6 M sucrose (15).  The 
wrinkled surface of the alginate-fibrin 
microbeads observed after warming using 
scanning electron microscopy was non-
detrimental to cell viability and functionality, as 
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confirmed by live/dead viability staining and 
metabolic assay. Recently the same protocol and 
VS was applied for the vitrification of human 
bone marrow MSCs attached on the surface of 
alginate microbeads coated by chitosan and 
collagen type I (175). It was shown (175) that 
the ability of MSCs cultured on the surface of 
microcarriers to proliferate was not affected by 
vitrification and it was significantly improved 
after vitrification compared to conventional slow 
cooling during continuous culture. Despite the 
benefits of vitrification the adaptation of cell 
cryo-banking towards clinical grade Good 
Manufacturing Practice (GMP) standards is 
required.  
(7): ALGINATE ENCAPSULATION FOR 
STORAGE OF CELLS AT NON-
FREEZING AND POSITIVE 
TEMPERATURES 
For some applications and for 
cryopreservation of recalcitrant species, tissues 
and cells, biopreservation in the non-frozen state 
has certain advantages. In the case of hydrated, 
human clinical biomaterials this concerns 
storage in the liquid (ice-free) condition. In 
contrast the successful preservation at positive 
temperatures of encapsulated, viable 
bioresources representing the wider spectrum of 
biodiversity usually requires a reduction in water 
content. This is optimized using osmotic 
treatments together with chemical and 
evaporative dehydration and desiccation (see 
Figs. 2 and 3) these regimes can simulate an 
organism's natural response to seasonal cues in 
nature, especially cold acclimation and seasonal 
dormancy which are adaptive survival strategies 
(9, 49). Generally, biopreservation at positive 
temperatures is aimed at allowing the short-term 
storage and distribution of biomaterials to end-
user laboratories and it may be attractive to 
avoid the extra costs and complexities associated 
with cryogenic preservation. This can be 
especially relevant in countries or regions where 
reliable access to cryogens such as LN, or 
electrical power to maintain low temperature 
freezers may be problematic. Similarly, the 
logistics of transferring and stabilizing at sub-
zero temperatures viable samples from remote 
field sites can be problematic (9),  in these 
situations, alginate encapsulation may have 
added benefits to already developed storage and 
handling regimens. Such approaches have been 
applied for a range of taxa although in historical 
terms, non-freezing AECryo technologies were 
developed first for plant germplasm deriving 
from the focus of interest in artificial seeds. 
    
Alginate encapsulation for the storage of plant 
propagules at positive temperatures  
Alginate artificial seed technology as 
applied to somatic embryos (91) can be adapted 
for other plant propagules including meristems 
(48, 68) and nodal segments (31). This permits 
the medium-term storage of a range of plant 
germplasm which can be achieved when bead 
MC and treatments are optimized to prevent 
deterioration or premature development of the 
propagules during storage or transport at positive 
temperatures. Assuring the stability and 
longevity of alginate encapsulated propagules at 
non-freezing temperatures requires the careful 
optimization and validation of medium-term 
storage parameters with acceptable recovery 
outcomes (24, 68, 102, 108). The conservation 
of encapsulated cotyledonary nodal segments 
from Cedrela fissilis for 3 months at 25ºC was 
possible with 90-100% recovery, although the 
propagules deteriorated by 6 months storage and 
their viability was reduced to 6-8% after 9 
months (31). Cedrela fissilis is an endangered 
tree native to the Brazilian South Atlantic Forest 
and this study demonstrates the potential use of 
encapsulation at positive temperatures for the ex 
situ conservation of at risk species. In the case of 
economically significant plants, Ikhlaq et al. (68) 
applied alginate encapsulation in artificial 
endosperm solution to shoot meristems of Olea 
europaea; acceptable levels of recovery were 
achieved after 45 days storage at 4ºC. 
Alternatively, Nower et al. (106) manipulated 
the storage longevity of alginate encapsulated 
meristems of Pyrus communis using growth 
retardants, an approach that may be useful for 
the synthetic seeds of species sensitive to low 
temperatures. Plant regeneration following 
medium term storage of alginate encapsulated 
somatic embryos, embryoids and embryogenic 
masses at 4ºC for 30 - 60 days has been achieved 
for Citrus reticulata (4) and Pistachio vera (108) 
respectively. Castillo et al. (24) demonstrated 
that alginate encapsulated embryos of Carica 
papaya survived 85 days storage under low light 
at 10ºC. In all cases alginate encapsulation 
improved post-storage survival of embryos 
compared to non-encapsulated controls.  
Whilst the storage of plant germplasm at 
positive temperatures has many advantages 
assuring the stability of plants regenerated from 
synthetic seeds is important, particularly as in 
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vitro culture and preservation at non-cryogenic 
temperatures can predispose plants to instability 
and genetic variation (56). Faisal et al. (48) 
assessed the genetic fidelity of plants 
regenerated from encapsulated micro-shoots of 
Rauvolifia serpentina, which were stored for 4 
weeks at 4ºC. Random amplified polymorphic 
DNA (RAPD) and inter-simple sequence repeat 
(ISSR) marker studies confirmed plantlets 
regenerated from the synthetic seeds of this 
medicinal plant were comparable to those of 
mother plants.  
 
Alginate encapsulation for hypothermic or 
positive temperature preservation of animal 
cells 
Efficient storage and transportation of the 
cells without affecting their functional activity 
and specific properties is an essential factor in 
any clinical and laboratory practice. For short-
term storage, it is often not necessary to use 
technically complex and costly cryobiological 
methods demanding of specialized equipment, 
trained staff and the use of toxic cryoprotectants, 
which should be washed out before use. At the 
same time, the period of time when cells and 
tissues can be stored at low positive temperature 
(4-23°C) is limited and this encourages the 
search for new and optimization existing 
approaches to extend the time without affecting 
the quality of the biological material. 
One of these approaches is the 
encapsulation of cells in a semipermeable 
alginate hydrogel. It has been shown that cell 
encapsulation can improve their viability during 
storage at low positive temperature without the 
use of specialized media and additives. Thus, in 
the study from Chen et al. (27), human MSCs 
and murine ESCs were successfully stored inside 
alginate hydrogels for 5 days under ambient 
conditions in an air-tight environment. Viability 
of the cells extracted from alginate gel compared 
favourably to cryopreservation: 74% for ESC 
and 80% for human MSC. More importantly, the 
subsequent proliferation rates and detection of 
common stem cell markers from human MSCs 
and ESCs retrieved from alginate hydrogels 
were also comparable to results gained following 
cryopreservation. Tarusin et al. (156) carried out 
a comparative study of viability, function and 
capacity for multilineage differentiation of 
human dermal MSCs, stored at various 
temperatures either as cell suspensions or within 
alginate microbeads. It has been shown that the 
storage of the MSCs at temperatures of 4, 22 and 
37°C in sealed cryovials in suspension for 3 days 
resulted in a decrease of the viability, attachment 
properties and metabolic activity. MSCs after 
storage within alginate microbeads at 22 and 
37°C showed a high viability (78 and 87%, 
respectively), retained the attachment properties 
(62 and 70%), metabolic activity (79 and 75%) 
and ability to differentiate towards osteogenic 
and adipogenic lineage.  
In another report, Swioklo et al. (152) 
examined whether hypothermic (4°C–23°C) 
preservation of human adipose-derived MSCs 
could be improved through their encapsulation 
in 1.2% calcium alginate. Alginate encapsulation 
improved the recovery of viable cells after 72 h 
of storage. Viable cell recovery was highly 
temperature dependent, with an optimum 
temperature of 15°C. At this temperature, 
alginate encapsulation preserved the ability for 
recovered cells to attach to tissue culture plastic 
on rewarming to normothermia, further 
increasing its effect on total cell recovery. On 
attachment, the cells were phenotypically 
normal, displayed normal growth kinetics and 
maintained their capacity for trilineage 
differentiation. The number of cells encapsulated 
did not affect viable cell recovery nor did 
storage of encapsulated cells in a xeno-free, 
serum-free, current GMP-grade medium. 
The influence of alginate encapsulation on 
the preservation of the cells in the storage 
conditions at 4°C without the use of specialized 
media and supplements remains controversial. 
Swioklo et al. (152) observed that at 4°C during 
72 h, non-encapsulated MSCs demonstrated a 
dramatic decrease in viability; compared to a 
yield of only about 18% of viable cells initially 
stored, encapsulated cells exhibited a 3.7-fold 
increase in the number of viable cells recovered 
compared to control. Experiments on the effects 
of hypothermic storage (4°C) up to 24 h upon 
cell viability and enzyme release in 1 or 1.5 % 
alginate beads containing baby hamster kidney 
clones overexpressing α -L-iduronidase (IDUA) 
were performed (96). It was shown that the 1% 
alginate group presented a small but not 
significant reduction in enzyme activity, while 
the 1.5% alginate group presented values for 
IDUA activity threefold those of the pre-storage 
levels. 
Mahler et al. (84) analysed the protective 
effects of alginate encapsulation on rat 
hepatocyte viability, cell yield, and both 
mitochondrial and other cytoplasmic functional 
activities, and apoptosis after either 24 or 48 h of 
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hypothermic storage. Decrease in viability was 
recorded at 4% and 13% (24 h at 4°C), 15% and 
33% (48 h at 4°C) for encapsulated and free 
suspended hepatocytes, respectively. The 
mitochondrial enzymes, EROD and GST 
activities were better preserved in encapsulated 
than in free suspended hepatocytes (84). 
Hypothermic storage processes were found to 
induce early caspase-3-like activities, being 
always much lower in alginate encapsulated 
hepatocytes. Thus, cold-induced apoptosis in 
hepatocytes can be significantly reduced 
following their encapsulation within alginate gel 
beads and this is associated with an 
improvement of both their viability and function. 
Analysis on the effects of alginate concentration, 
storage conditions and period of encapsulation 
on cell viability to examine the suitability of a 
calcium alginate hydrogel for preservation of 
corneal epithelial cells was carried out by 
Wright et al. (174). It was demonstrated that 
0.6% (w/v) alginate gel composition allowed 
storage of corneal epithelial cells most 
effectively in either a hypothermic (4°C, 
atmospheric CO2 and humidity levels) or cell 
culture environment for up to 5 days. 
Modification of the macrostructure of a calcium 
alginate gel from an amorphous mass to a thin 
disc enhanced corneal epithelial cell viability, 
limited cell proliferation and overcame the 
reduction in cell viability observed with 
increases in alginate concentration. The authors 
noted that viability of cells encapsulated within 
calcium alginate gels was influenced by both 
pore size and mechanical properties (174). The 
extent to which these structural features affect 
cell viability may be manipulated by modifying 
proportions of alginate and porogen (HEC) in 
gels. All these data support a beneficial effect of 
alginate upon cell viability and function after 
hypothermic storage (4-8°C). 
In contrast, other studies failed to show a 
positive effect of alginate encapsulation at 
hypothermic storage (4°C) or in attempts to 
extend the storage periods without using 
specialised additives (see following discussion).  
Hypothermic storage presented as harsh 
conditions for encapsulated (in alginate-PLO-
alginate microcapsules) buffalo rat liver cell line 
propagation and the secretion of metabolic 
products (179). When the storage temperature 
was 4°C, there was no obvious difference 
between cells re-cultured for 1 day and 3 days, 
cell viability was very low and the remaining 
living cells were hardly able to propagate. 
Hypothermic storage of human dermal MSCs 
within alginate microbeads at 4°C resulted in a 
gradual decrease of viability during 3 and 7 
days; and at the end of storage no significant 
differences between cells in suspension or in 
alginate microspheres were observed (156, 159). 
Despite the fact that investigators in some 
studies managed to achieve a positive result of 
encapsulation at hypothermic storage 
temperatures (4-8°C), one must conclude that 
these results were obtained only after short time 
windows. Perhaps more prolonged storage of 
cells without the use of specialized media and 
additives will have a dramatic effect on the cells’ 
fate irrespective of alginate encapsulation. 
For this purpose, in the report by Tarusin et 
al. (158) the effect of hypothermic storage at 
4°C of human MSCs as suspension or 
encapsulated in alginate microspheres was 
studied using sucrose-based solution (SBS) (74) 
and the University of Wisconsin solution (UW). 
It was shown that after 7 days at hypothermic 
storage in SBS and UW, suspensions of MSCs 
and MSCs encapsulated in alginate microspheres 
retained high levels of viability (60-80%), 
adhesive properties, metabolic activity and the 
ability to induced adipogenic and osteogenic 
differentiation. Thus, this confirmed that the use 
of preservation solutions SBS and UW can 
prolong hypothermic storage of the MSCs. 
However, the positive influence of alginate 
encapsulation compared to cell suspension was 
not identified. 
Other factors may impact on the viability of 
the alginate encapsulated cells at positive 
temperatures during storage. Thus, the purpose 
of the study by Dontchos et al. (40) was to 
determine whether an increase in pH decreased 
chondrocyte viability during cold storage in 
alginate microbeads and whether equilibration of 
Dulbecco’s modified Eagle’s medium (DMEM) 
in 5% CO2 normalized pH and increased 
chondrocyte survival during storage at 4°C. 
After 5 days of storage in alginate microbeads at 
+4°C, chondrocyte necrosis was higher when 
stored in ambient air than if equilibrated with 
5% CO2. These data show that an increase in pH 
decreased bovine chondrocyte viability when 
refrigerated at +4°C in DMEM, and that 
optimization of CO2 with normalized pH did 
improve chondrocyte viability during cold 
storage in DMEM. 
Any positive effect of alginate 
encapsulation on cell state during storage may 
be based on a number of up to now unidentified 
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factors. Protective effects may be caused directly 
by the alginate matrix, but can result from an 
indirect influence. Hypothetically, by stabilizing 
plasma membranes, the alginate gel could 
provoke integrin ligation, which disrupts the 
integrin-caspase complex and thus increases 
survival, thereby revealing an unexpected role 
for entrapment in alginate beads in the 
regulation of apoptosis (84). Further study is 
needed to clarify this hypothesis because not all 
cells are subject to integrin-mediated death, and 
not all integrins are pro-apoptotic. Indirect 
effects of the alginate hydrogel may result from 
its mass transfer and diffusive characteristics 
confirmed for different molecular weight solutes 
(116). Thus, the spatial separation of the cells 
from each other could positively impact by 
decreasing proteolytic enzymes released and 
diffusion of factors from the dead cells to viable 
ones. One cause of a positive effect of alginate 
encapsulation also may result from reversible 
total metabolic inhibition and decrease in 
mitochondrial membrane potential, as it has 
been shown in culture of encapsulated 
fibroblasts (67). In support of this mechanism it 
could be suggested as a weak, positive cell 
response to encapsulation during storage at 4°C, 
where independently of the presence of the 
alginate hydrogel, cells are already in the low 
metabolic state (159).  
The overall results discussed here show that 
the selection of temperature conditions, 
environment and physicochemical properties of 
alginate will allow us to develop a technology 
which may significantly prolong the effective 
short-term storage of cells for their safe transport 
and exchange between clinical and experimental 
centres. Muller et al. (102) debate the possibility 
of ambient, positive temperature storage of 
nucleic acids in terms of logistics, safety, and 
cost and conclude that it is of value only if the 
stability of the samples is adequate. Although 
there are advantages associated with the storage 
and transport of alginate encapsulated 
biomaterials and viable bioresources at positive 
temperatures, it is recommended that these 
biopreservation methods are validated before 
they are used routinely. In particular, their 
evaluation should include the future proofing of 
post-storage quality and stability (102). 
 
CONCLUSIONS 
Alginate encapsulation cryopreservation 
was originally pioneered for the ex situ 
conservation of plant genetic resources and 
AECryo protocols have now been validated for 
routine use in some plant genebanks and 
biorepositories. The encapsulation of viable 
cells, tissues, organs and organisms in alginate 
provides an alternative, low temperature storage 
method enabling the successful cryopreservation 
of bioresources representing diverse taxonomic 
groups and, more recently, clinical and 
therapeutic biospecimens. AECryo has similarly 
been applied in algal, microbial, fungal and 
protist culture collections and is particularly 
useful for the storage of organisms that have 
proved difficult (recalcitrant) to cryopreserve 
using traditional protocols. Moving forward, 
there remain important factors to consider 
alongside further expansion of AECryo. 
Different alginate sources, with different 
polymer mixes (and therefore different physical 
characteristics), may provide subtle differences 
in successful stability in the cryopreserved state. 
In terms of AECryo safety, bio-contamination of 
alginate may be more or less important. For 
example, for human application, alginate may 
require stringent purification steps to remove 
bio-contaminants. Some of these factors have 
been recently reviewed (109). In AECryo for 
plant, algae and fungi, it seems so far, that 
contamination introduced via poor containment, 
inadequate aseptic techniques, cross-
contamination and use of non-axenic cultures 
(e.g., that contain systemic endophytes) before 
cryopreservation have been the main identified 
problems, rather than the alginate itself. Thus, 
we can conclude that, almost three decades after 
it was first pioneered, AECryo technology 
currently enables the long-term storage of 
bioresources across diverse clinical and non-
clinical sectors, including agriculture, 
biotechnology, conservation, forestry, 
horticulture and environmental sciences.   
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